Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy
- 1 February 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 87 (2) , 266-271
Abstract
SUMMARY: Evidence now suggests that cosinophils and T lymphocytes infiltrating bronchial tissues may play a key role in the pathophysiology of asthma. Circulating cosinophils, lung function, and plasma soluble IL-2 receptor (sIL-2R) were measured in 42 asthmatic patients referred for symptomatic asthma. The patients were divided into two groups based on the presence or absence of atopy. The group of non-atopic asthmatics was further divided according to the patients’ requirement for long term oral corticosteroids. The mean sIL-2R ± s.d. was 36.3 ± 9.9 pM in the control group, 28.9 ± 9.2 pM in the atopic asthmatics, 43.3 ±18.07 pM in the non-atopic asthmatics without oral steroid therapy, but was increased in the steroid-treated group (62.2 ±19-3 pM, P<0.01). A significant correlation was found between I-FEV1 and circulating cosinophils in atopic asthmatics and in non-atopic asthmatics without oral corticosteroid therapy, but not in the steroid-treated group. Furthermore, significant correlations were found between sIL-2R and FEV1 and between sIL-2R and blood eosinophils, in the group of non-atopic asthmatics not on oral steroid therapy. No such correlations were evidenced in the other groups of asthmatics. Similar results were obtained during the clinical course of three non-atopic patients followed for more than I year. These data suggest that T cell activation appears more prominent in non-atopic asthma than in atopic asthma. Moreover, it appears that T cell activation can occur in severe forms of asthma despite steroid treatment. Finally, the results suggest a possible link between T cell activation, eosinophils. and lung function, which may reflect a particular pathogenetic mechanism involved in non-atopic asthma.Keywords
This publication has 15 references indexed in Scilit:
- Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophiliaJournal of Allergy and Clinical Immunology, 1991
- The Soluble Interleukin-2 Receptor: Biology, Function, and Clinical ApplicationAnnals of Internal Medicine, 1990
- Eosinophilic Inflammation in AsthmaNew England Journal of Medicine, 1990
- Quantitation of Mast Cells and Eosinophils in the Bronchial Mucosa of Symptomatic Atopic Asthmatics and Healthy Control Subjects Using ImmunohistochemistryAmerican Review of Respiratory Disease, 1990
- T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMAThe Lancet, 1988
- DIFFERENCE BETWEEN HERPES SIMPLEX VIRUS TYPE I AND TYPE 2 NEONATAL ENCEPHALITIS IN NEUROLOGICAL OUTCOMEThe Lancet, 1988
- Peripheral blood eosinophil counts and bronchial responsiveness.Thorax, 1987
- Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactionsClinical & Experimental Allergy, 1985
- IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMAThe Lancet, 1982
- Aspirin intolerance in asthmaJournal of Allergy and Clinical Immunology, 1972